Effects of Vaccination on Invasive Pneumococcal Disease in South Africa
Authors:
- Anne von GottbergAGAnne von Gottberg
- Linda de GouveiaLGLinda de Gouveia
- Stefano TempiaSTStefano Tempia
- Vanessa QuanVQVanessa Quan
- Susan MeiringSMSusan Meiring
- Claire von MollendorfCMClaire von Mollendorf
- Shabir A. MadhiSMShabir A. Madhi
- Elizabeth R. ZellEZElizabeth R. Zell
- Jennifer R. VeraniJVJennifer R. Verani
- Katherine L. O’bRienKOKatherine L. O’bRien
- Cynthia G. WhitneyCWCynthia G. Whitney
- Keith P. KlugmanKKKeith P. Klugman
Top Cited Papers
- 13 November 2014
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 371 (20) , 1889-1899
Abstract
In South Africa, a 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in 2009 with a three-dose schedule for infants at 6, 14, and 36 weeks of age; a 13-valent vaccine (PCV13) replaced PCV7 in 2011. In 2012, it was estimated that 81% of 12-month-old children had received three doses of vaccine. We assessed the effect of vaccination on invasive pneumococcal disease.Keywords
This publication has 30 references indexed in Scilit:
- Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: Translating research into policyVaccine, 2012
- Prevention of Antibiotic-Nonsusceptible Streptococcus pneumoniae With Conjugate VaccinesThe Journal of Infectious Diseases, 2011
- Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort studyThe Lancet Infectious Diseases, 2011
- Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunizationAIDS, 2010
- Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate VaccineThe Journal of Infectious Diseases, 2010
- Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimatesThe Lancet, 2009
- Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccineVaccine, 2007
- Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-ResistantStreptococcus pneumoniaeNew England Journal of Medicine, 2006
- Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trialThe Lancet, 2005
- A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children with and Those without HIV InfectionNew England Journal of Medicine, 2003